HBV inhibits apoB production via the suppression of MTP expression

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Wang, Fu Bing ^a   Zhu, Cheng Liang ^b   Liu, Xinghui ^c   Gao, Guo Sheng ^d  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

^d NINGBO NO 2 HOSPITAL   (China)

Author keywords

apolipoprotein B; chronic HBV infection; lipid metabolism; hepatitisB virus; microsomal triglyceride transfer protein

Indexed keywords

APOLIPOPROTEIN B; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; CARRIER PROTEIN;

ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; CELL STRAIN HEPG2; DOWN REGULATION; GENE EXPRESSION; GENETICS; METABOLISM;

HEPATITIS B VIRUS;

APOLIPOPROTEINS B; CARRIER PROTEINS; CASE-CONTROL STUDIES; DOWN-REGULATION; GENE EXPRESSION; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; RNA, MESSENGER;

EID: 81055138802     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-207     Document Type: Article

References (27)

1. The natural history of chronic hepatitis B virus infection. McMahon BJ, Hepatology 2009 49 5 Suppl 45 55 19399792
2. HBV induced carcinogenesis. Cougot D, Neuveut C, Buendia MA, J Clin Virol 2005 34 Suppl 1 75 8 16461244
3. Immunopathogenesis of hepatitis B virus infection. Chang JJ, Lewin SR, Immunol Cell Biol 2007 85 1 16 23 10.1038/sj.icb.7100009 17130898 (Pubitemid 46067317)
4. Prevention of hepatitis B virus-related hepatocellular carcinoma. Lok AS, Gastroenterology 2004 127 5 Suppl 1 303 9 15508098
5. The host-pathogen interaction during HBV infection: immunological controversies. Bertoletti A, Maini MK, Ferrari C, Antivir Ther 2010 15 Suppl 3 15 24 10.3851/IMP1620 21041900
6. ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes. Skogsberg J, Dicker A, Rydén M, Aström G, Nilsson R, Bhuiyan H, Vitols S, Mairal A, Langin D, Alberts P, Walum E, Tegnér J, Hamsten A, Arner P, Björkegren J, PLoS One 2008 3 11 3771 10.1371/journal.pone.0003771 19020660
7. Apolipoprotein A1 and B. Sniderman AD, Marcovina SM, Clin Lab Med 2006 26 4 733 50 10.1016/j.cll.2006.07.007 17110237 (Pubitemid 44716511)
8. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. hovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C, Lipid Res 2004 45 7 1169 96 10.1194/jlr.R300019-JLR200 (Pubitemid 38802622)
9. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. Hussain MM, Shi J, Dreizen P, J Lipid Res 2003 44 1 22 32 10.1194/jlr.R200014-JLR200 12518019 (Pubitemid 36114766)
10. The assembly and secretion of apolipoprotein B-containing lipoproteins. Olofsson SO, Asp L, Borén J, Curr Opin Lipidol 1999 10 4 341 6 10.1097/00041433-199908000-00008 10482137 (Pubitemid 29419691)
11. The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Mohamadkhani A, Sayemiri K, Ghanbari R, Elahi E, Poustchi H, Montazeri G, Virol J 2010 7 228 10.1186/1743-422X-7-228 20840785
12. Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. Norton PA, Gong Q, Mehta AS, Lu X, Block TM, J Virol 2003 77 9 5503 6 10.1128/JVI.77.9.5503-5506.2003 12692252 (Pubitemid 36460964)
13. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Zhu C, Zhang R, Liu L, Rasool ST, Mu Y, Sun W, Hao Q, Liu F, Zhu Y, Wu J, Clin Immunol 2009 131 1 92 7 10.1016/j.clim.2008.10.011 19081304
14. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. Olofsson SO, Borèn J, J Intern Med 2005 258 5 395 410 10.1111/j.1365-2796.2005.01556.x 16238675 (Pubitemid 41546555)
15. Synthesis and function of hepatic very-low-density lipoprotein. Gibbons GF, Wiggins D, Brown AM, Hebbachi AM, Biochem Soc Trans 2004 32 Pt 1 59 64 14748713 (Pubitemid 38283014)
16. Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication. Gu JG, Zhu CL, Cheng DZ, Xie Y, Liu F, Zhou X, Lipids Health Dis 2011 10 154 10.1186/1476-511X-10-154 21875437
17. Role of lipid metabolism in hepatitis C virus assembly and entry. Popescu CI, Dubuisson J, Biol Cell 2009 102 1 63 74 10.1042/BC20090125 19857204
18. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP, Gastroenterology 2004 126 2 586 97 10.1053/j.gastro.2003.11.020 14762795 (Pubitemid 38182315)
19. Associations between serum lipids and hepatitis C antiviral treatment efficacy. Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ, Virahep-C Study Group, Hepatology 2010 52 3 854 63 10.1002/hep.23796 20690192
20. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection. Zhu C, Zhang R, Liu D, Mukhtar MM, Liu W, Peng G, Wang K, Hao Q, Xu Y, Liu F, Zhu Y, Wu J, Clin Chim Acta 2009 401 1-2 124 7 10.1016/j.cca.2008.12.001 19083997
21. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. Siagris D, Christofidou M, Theocharis GJ, Pagoni N, Papadimitriou C, Lekkou A, Thomopoulos K, Starakis I, Tsamandas AC, Labropoulou-Karatza C, J Viral Hepat 13 1 56 61
22. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. Wang AG, Lee DS, Moon HB, Kim JM, Cho KH, Choi SH, Ha HL, Han YH, Kim DG, Hwang SB, Yu DY, J Pathol 2009 219 2 253 62 10.1002/path.2592 19621337
23. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Feitelson MA, Reis HM, Tufan NL, Sun B, Pan J, Lian Z, Cancer Lett 2009 286 1 69 79 10.1016/j.canlet.2008.12.010 19201080
24. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. Kang SK, Chung TW, Lee JY, Lee YC, Morton RE, Kim CH, J Biol Chem 2004 279 27 28106 12 10.1074/jbc.M403176200 15123606 (Pubitemid 38900083)
25. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. Kulinski A, Rustaeus S, Vance JE, J Biol Chem 2002 277 35 31516 25 10.1074/jbc.M202015200 12072432 (Pubitemid 34968953)
26. Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: implications in lipoprotein biosynthesis. Hussain MM, Bakillah A, Jamil H, Biochemistry 1997 36 42
27. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP: Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004, 126(2):586-97. (Pubitemid 38182315)